ARGA Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

ARGA Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.5M	Buy	+1,039,409	New	+$56.9M	1.52%	19

Other funds holding BMRN

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return

ARGA Investment Management's BMRN Position: Q2 2026 in Review

ARGA Investment Management opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 1,039,409 shares worth $59.5M. The stake represents 1.52% of the portfolio and ranks #19 among its holdings.

159 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

ARGA Investment Management held 1,039,409 shares of BioMarin Pharmaceuticals worth $59.5M as of Q2 2026.
BioMarin Pharmaceuticals was a new ARGA Investment Management position in Q2 2026.
BioMarin Pharmaceuticals made up 1.52% of ARGA Investment Management's portfolio in Q2 2026, its #19 holding.
159 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on ARGA Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.